During the past decade, Ophthalmology Associates conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ophthalmology Associates" #1 sponsor was "Sight Sciences, Inc." with 3 trials, followed by "ForSight Vision5, Inc." with 2 trials sponsored, "InnFocus Inc." with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Glaukos Corporation" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ophthalmology Associates" #1 collaborator was "Parexel" with 1 trials as a collaborator and "University of Pittsburgh" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ophthalmology Associates" are "Glaucoma, Open-Angle" (3 trials), "Glaucoma and Ocular Hypertension" (2 trials), "Ocular Hypertension" (2 trials), "Primary Open-Angle Glaucoma" (2 trials) and "Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Ophthalmology Associates" in a lesser frequency.

Most popular intervention types in "Ophthalmology Associates" are "Device" (6 trials), "Drug" (5 trials), "Procedure" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bimatoprost" (2 trials), "OMNI® Surgical System" (2 trials), "ABP 938" (1 trials), "Aflibercept" (1 trials) and "Bevasiranib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ophthalmology Associates" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Ophthalmology Associates". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ophthalmology Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ophthalmology Associates, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".